Patel Samir Rashmikant 13D/13G Filings for Akari Therapeutics, Plc (AKTX)

Patel Samir Rashmikant 13D and 13G filings for Akari Therapeutics, Plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
4:05 pm
Purchase		2022-12-3113GAkari Therapeutics, Plc
AKTX		Patel Samir Rashmikant393,102
9.900%		209,198increase
(+113.75%)		Filing
2022-02-14
08:02 am
Purchase		2021-12-3113GAkari Therapeutics, Plc
AKTX		Patel Samir Rashmikant183,904
6.200%		59,285increase
(+47.57%)		Filing
2021-02-16
08:31 am
Purchase		2020-12-3113GAkari Therapeutics, Plc
AKTX		Patel Samir Rashmikant124,619
7.200%		48,417increase
(+63.54%)		Filing